Navigation Links
Treatment for Rett Syndrome Moves a Step Closer as Rett Syndrome Research Trust Commits Record $4.2 million in 2012
Date:2/14/2013

Trumbull, CT (PRWEB) February 14, 2013

The Rett Syndrome Research Trust (RSRT) affirmed its mission to drive innovative science by awarding $4.2 million in 2012. This amount represents the largest research commitment in a given year ever allocated by a Rett organization. The awards were made possible by the fundraising efforts of highly motivated families and supporters of children and adults with Rett Syndrome in the US, and through our global partnership with Rett Syndrome Research Trust UK and Rett Syndrome Research & Treatment Foundation (Israel).

Rett Syndrome, the most physically disabling of the autism spectrum disorders, is caused by random mutations in the gene MECP2. Predominantly affecting girls, a frightening regression in toddlerhood robs children of the ability to speak, move normally and use their hands. Disordered breathing, Parkinsonian tremors, severe anxiety, seizures, digestive, circulatory and orthopedic problems typically appear. Although most children survive to adulthood they require total round-the-clock care.

“Our goal is not to fund research but to fund results. Ultimately, the measure of our success will not be in terms of dollars spent but whether we will have dramatically improved the quality of life of the people we serve – children and adults with Rett Syndrome. We believe the projects we chose to support in 2012 will help us achieve that goal,” said Tony Schoener, Chairman of the Board of RSRT.

RSRT awarded funds in 2012 to the following projects:

  •     $2.2 million was awarded to Benjamin Philpot at the University of North Carolina at Chapel Hill and his collaborators, Bryan Roth and Terry Magnusson. Their bold project is a screening initiative to identify compounds able to reactivate the silenced but healthy MECP2 gene on the inactive X chromosome. RSRT has championed this approach since the game-changing discov
    '/>"/>

Source: PRWeb
Copyright©2012 Vocus, Inc.
All rights reserved

Page: 1 2 3 4

Related biology technology :

1. Non Invasive Bed Bug Treatments Offered to a State Library Shutdown Due to Sightings of Bed Bugs, MyCleaningProducts.com Details the Treatments' Process
2. An article from Bloomberg.com discusses Ban on a Common Acne Treatment; Probiotic Action Comments On the product Ban
3. Genesis Biosystems Unveils Innovative Skin Treatment at Esthétique SPA International Trade Show
4. Pictures of Bed Bugs and Non-Pesticide Product Cut Bed Bug Treatment Expenses by Half, My Cleaning Products Explains the Details in a Guide
5. ALS Patients’ Own Stem Cells Show Promise as a Future Treatment Option
6. American Heart Month: Find New Heart Disease Treatments on cureLauncher
7. BIOWATER Wastewater Treatment Package Plant Arrives in Residential Neighborhoods
8. Transition in cell type parallels treatment response, disease progression in breast cancer
9. Total Knee Replacement May Be Delayed by Up To Ten Years with an Arthroscopic Knee Surgery Treatment Known as the “Package”
10. Dr. Ross Kaplan Offers New Comprehensive Acne Package Treatment for Acne and Acne Scarring
11. Migraines Found Linked to Nighttime Teeth Grinding & Clenching in TMJ Treatment Clinical Trial - Holistic Technologies
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/19/2014)... 18, 2014  Decision Resources Group finds that the ... will grow moderately through 2023 as the aging population, ... of dental biomaterials all spur procedure volumes. Growth will ... China and India ... within reach for a larger proportion of the population. ...
(Date:12/17/2014)... The Activated Carbon Manufacturing ... why IBISWorld updated its original industry research report. ... an intensified focus on environmental policy. Over the five ... for power plants and a range of other industrial ... Analyst Sarah Kahn, “a range of downstream industrial sectors ...
(Date:12/17/2014)... 2014 Ipsen Biopharmaceuticals, Inc., an ... IPSEY), today announced that Somatuline® Depot® ... was approved by the U.S. Food and Drug ... tumors (GEP-NETs) in adult patients with unresectable, well ... to improve progression-free survival (PFS). , “The approval ...
(Date:12/17/2014)... (PRWEB) December 17, 2014 Gene ... that it has entered into a technology access ... (ADM) to apply DNA2.0’s proprietary protein engineering technology, ... process. , “We are extremely excited that the ... platform. This proprietary bioengineering technology has now ...
Breaking Biology Technology:Asia Pacific Dental Biomaterial Market Will Grow Strongly Through 2023 2Asia Pacific Dental Biomaterial Market Will Grow Strongly Through 2023 3Activated Carbon Manufacturing in the US Industry Market Research Report Has Been Updated from IBISWorld 2Activated Carbon Manufacturing in the US Industry Market Research Report Has Been Updated from IBISWorld 3Ipsen Announces the FDA Approval of Somatuline® Depot® (lanreotide) Injection for the Treatment of Gastroenteropancreatic Neuroendocrine Tumors 2Ipsen Announces the FDA Approval of Somatuline® Depot® (lanreotide) Injection for the Treatment of Gastroenteropancreatic Neuroendocrine Tumors 3Ipsen Announces the FDA Approval of Somatuline® Depot® (lanreotide) Injection for the Treatment of Gastroenteropancreatic Neuroendocrine Tumors 4Ipsen Announces the FDA Approval of Somatuline® Depot® (lanreotide) Injection for the Treatment of Gastroenteropancreatic Neuroendocrine Tumors 5Ipsen Announces the FDA Approval of Somatuline® Depot® (lanreotide) Injection for the Treatment of Gastroenteropancreatic Neuroendocrine Tumors 6Ipsen Announces the FDA Approval of Somatuline® Depot® (lanreotide) Injection for the Treatment of Gastroenteropancreatic Neuroendocrine Tumors 7Ipsen Announces the FDA Approval of Somatuline® Depot® (lanreotide) Injection for the Treatment of Gastroenteropancreatic Neuroendocrine Tumors 8ADM and DNA2.0 Enter Into Protein Engineering Technology Access and Service Agreement 2
... 16 /Xinhua-PRNewswire-FirstCall/ -- Pharmaxis (ASX: PXS;,Nasdaq: PXSL) today ... for its asthma management product, Aridol., "This ... Pharmaxis Chief,Executive Officer Dr Alan Robertson. "Korea is ... Aridol in Asia. There are an estimated 2.5 ...
... 16 /PRNewswire-FirstCall/ - Vasogen Inc.,(NASDAQ: VSGN ; TSX:VAS), ... year ended November 30, 2007. All dollar amounts ... At November 30, 2007, our cash and ... at November 30, 2006. The change in,our cash ...
... 16 Bristol-Myers Squibb,Company (NYSE: BMY ) will ... 2007 on Thursday, January 31. During a 10 a.m. ... financial information and will,address inquiries from investors and analysts., ... listen to a live,webcast of the call at ...
Cached Biology Technology:Pharmaxis' Aridol Gains First Asian Approval 2Vasogen Announces 2007 Year-End Results 2Vasogen Announces 2007 Year-End Results 3Vasogen Announces 2007 Year-End Results 4Vasogen Announces 2007 Year-End Results 5Vasogen Announces 2007 Year-End Results 6Vasogen Announces 2007 Year-End Results 7Vasogen Announces 2007 Year-End Results 8Vasogen Announces 2007 Year-End Results 9Vasogen Announces 2007 Year-End Results 10Vasogen Announces 2007 Year-End Results 11
(Date:12/15/2014)... , Dec. 12, 2014 Research and Markets ... addition of the "Global Facial Recognition Market ... http://photos.prnewswire.com/prnh/20130307/600769 Facial ... of individuals. Facial recognition system measures the overall ... jaw edges, mouth, and the distance between eyes. ...
(Date:12/11/2014)... Dec. 09, 2014 Research and Markets ... ( http://www.researchandmarkets.com/research/9ql3kr/biometrics_market ) has announced the ... 2015-2019" report to their offering. ... is the adoption of multimodal biometric systems. Multimodal ... an individual for verification and identification purposes. This ...
(Date:12/11/2014)... Minn. , Dec. 10, 2014  Data ... physiologic monitoring, has released a new series of ... of preclinical toxicology researchers. M series, part of ... toxicologists collect the best possible physiologic data when ... Adding functional endpoints to toxicology studies has ...
Breaking Biology News(10 mins):Global Facial Recognition Market 2015-2019: Key Vendors are 3M Cogent, Cognitec Systems, NEC and Safran Group 2Global Facial Recognition Market 2015-2019: Key Vendors are 3M Cogent, Cognitec Systems, NEC and Safran Group 3Biometrics Market in India 2015-2019: Key Vendors are 3M Cogent, NEC, Safran and Suprema 2New telemetry implants expected to change how large animal toxicology studies are conducted 2
... further refined the recently developed TEX 86 paleothermometer ... Institute for Sea Research (NIOZ). The thermometer measures ... composition of archeabacteria. Real thermometers have been ... before this, researchers depend on signs from nature. ...
... phosphorus releases into the Everglades seem sufficient to protect ... but pollutant levels still reach double or triple safe ... A six-year study led by Duke University scientists tracked ... research sites inside the Everglades. In an Oct. ...
... Institute have described how an existing genetic tool can ... differentiate. The research appears in the November 2007 issue ... little about how human embryonic stem cells (hESC) self-renew. ... pluripotency, and their regulation, it is necessary to efficiently ...
Cached Biology News:Texel paleothermometer for climate reconstruction perfected 2Everglades phosphorus limits on the right track, but more is needed 2Everglades phosphorus limits on the right track, but more is needed 3